Filing Details

Accession Number:
0001209191-22-002468
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-07 17:14:37
Reporting Period:
2021-12-01
Accepted Time:
2022-01-07 17:14:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490829 James Jones 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-01 21 $4.14 18,963 No 4 P Direct
Common Stock Acquisiton 2021-12-02 21 $3.84 18,984 No 4 P Direct
Common Stock Acquisiton 2021-12-03 21 $4.47 19,005 No 4 P Direct
Common Stock Acquisiton 2021-12-06 21 $4.46 19,026 No 4 P Direct
Common Stock Acquisiton 2021-12-07 21 $5.61 19,047 No 4 P Direct
Common Stock Acquisiton 2021-12-08 21 $6.15 19,068 No 4 P Direct
Common Stock Acquisiton 2021-12-09 21 $5.81 19,089 No 4 P Direct
Common Stock Acquisiton 2021-12-10 21 $4.82 19,110 No 4 P Direct
Common Stock Acquisiton 2021-12-13 30 $4.36 19,140 No 4 P Direct
Common Stock Acquisiton 2021-12-14 30 $4.28 19,170 No 4 P Direct
Common Stock Acquisiton 2021-12-15 30 $4.29 19,200 No 4 P Direct
Common Stock Acquisiton 2021-12-16 50 $4.53 19,250 No 4 P Direct
Common Stock Acquisiton 2021-12-17 50 $4.17 19,300 No 4 P Direct
Common Stock Acquisiton 2021-12-20 65 $4.33 19,365 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.